Quercetin and the Growth of Leukemic Progenitors

References

• Harborne J. B. Flavonoids in the environment: structure-activity relationships. Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medical Properties, V. Cody, E. Middleton, Jr., J. B. Harbome, A. Beretz. Alan R. Liss, Inc., New York 1988; 17–29
   Google Scholar
• Wollenweber E. Occurence of flavonoid aglycones in medicinal plants. Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medical Properties, V. Cody, E. Middleton, Jr., J. B. Harborne, A. Beretz. Alan R. Liss, Inc., New York 1988; 17–29
   Google Scholar
• KÜHnau J. The flavonoids, a class of semi-essential food components: their role in human nutrition. Wld. Rev. Nutrition Diet 1976; 24: 117–191
   PubMedGoogle Scholar
• Bjeldanese L. F., Chang G. W. Mutagenic activity of quercetin and related compounds. Science 1977; 197: 577–578
   PubMed Web of Science ®Google Scholar
• Macgregor J. T. Genetic toxicology of dietary flavonoids. Prog. Clin. Biol. Res. 1986; 213: 33–43
   Google Scholar
• Ambrose A. M., Robbins D. J., Deeds F. comparative toxicities of quercetin and quercitrin. J. Am. Pharm. Assoc 1951; 41: 119–122
   Google Scholar
• Levy J., Teverstein I., Marbach M., Radian S., Sharoni Y. Tyrosine protein Kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin. Bichem. Biophys. Res. Commun. 1984; 123: 1227–1233
   PubMed Web of Science ®Google Scholar
• Cochet C., Feige J. J., Pirollet F., Keramidas M., Chambaz E. M. Selective inhibition of a cyclic nucleotide-independent protein kinase (G type casein kinase) by quercetin and related polyphenols. Biochem. Pharmacol. 1982; 31: 1357–1361
   PubMed Web of Science ®Google Scholar
• Gschwendt M., Horn F., Kittstein W., Marks F. Inhibition of the calcium- and phospholipid-dependent protein kinase activity from brain mouse cytosol by quercetin. Biochem. Biophys. Res. Commun. 1983; 117: 444–447
   PubMed Web of Science ®Google Scholar
• Srivastava A. K. Inhibition of phosphorylase kinase and tyrosine protein kinase activities by quercetin. Biochem. Biophys. Res. Commun. 1985; 131: 1–5
   PubMed Web of Science ®Google Scholar
• Matter W. F., Brown R. F., Vlahos C. J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophys. Res. Commun. 1992; 186: 624–631
   PubMed Web of Science ®Google Scholar
• Belt J. A., Thomas J. A., Buchsbaum R. N., Racker E. Inhibition of lactate transport and glycolisis in Ehrlich ascites tumor cells by bioflavonoids. Biochemestry 1979; 18: 3506–3511
   PubMed Web of Science ®Google Scholar
• Graziani Y., Chayoth R. Regulation of cyclic AMP level and synthesis of DNA, RNA and protein by quercetin in Ehrlich ascites tumor cells. Biochem. Pharmacol. 1979; 28: 397–403
   PubMed Web of Science ®Google Scholar
• Kuriki Y., Racker E. Inhibition of (Na+ K+) adenosine triphosphatase and its partial reactions by quercetin. Biochemestry 1976; 15: 4951–4956
   PubMed Web of Science ®Google Scholar
• Shoshan V., Mac Lennan D. H. Quercetin interaction with the (Cn++ Mg++)-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 1981; 256: 887–892
   PubMed Web of Science ®Google Scholar
• Hosokawa N., Hirayoshi K., Nakai A., Hosokawa Y., Marui N., Yoshida M., Sakai T., Nishino H., Aoike A., Kawai K., Nagata K. Flavonoids inhibit the expression of heat shock proteins. Cell Struct. Fund 1990; 15: 393–401
   PubMed Web of Science ®Google Scholar
• Hosokawa N., Hirayoshi K., Kudo H., Takechi H., Aoike A., Kawai K., Nagata K. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol. Cell. Biol. 1992; 12: 3490–3498
   PubMed Web of Science ®Google Scholar
• Lee Y. J., Erdos G., Hou Z.-Z., Kim S. H., Kim J. H., Cho J. M., Perry P. M. Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells. Mol. Cell. Biochem. 1994; 137: 141–154
   PubMed Web of Science ®Google Scholar
• Suolinna E. M., Buchsbaum R. N., Racker E. The effect of flavonoid on aerobic glycolysis and the growth of tumor cells. Cancer Res. 1975; 35: 1865–1872
   PubMed Web of Science ®Google Scholar
• Verma A., Johnsons J. A., Gould M. N., Tanner M. A. Inhibition of 7 12-dimethylbenz(a)anthracene and N-nitro-somethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 1988; 48: 5754–5758
   PubMed Web of Science ®Google Scholar
• Markaverich B. M., Roberts R. R., Alejandro M. A., Johnnan G. A., Middleditch B. S., Clark J. M. Bioflavonoid interaction with rat uterine type II binding sites and growth inhibition. J. Steroid Biochem. 1988; 30: 71–78
   PubMedGoogle Scholar
• Scambia G., Ranelletti F. O., Benedetti Panici P., Piantelli M., Bonanno G., De Vincenzo R., Ferrandina G., Rumi C., Larocca L. M., Mancuso S. Inhibitory effect of quercetin onOVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumors and cultured cells. Br. J. Cancer 1990; 62: 942–946
   PubMed Web of Science ®Google Scholar
• Scambia G., Ranelletti F. O., Benedetti Panici P., Piantelli M., Bonanno G., De Vincenzo R., Ferrandina G., Pierelli L., Capelli A., Mancuso S. Quercetin inhibits the growth of a mul-tidrug-resistant estrogen-receptor-negative MCF-7 human brest-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother. Pharmacol. 1991; 28: 255–261
   PubMed Web of Science ®Google Scholar
• Ranelletti F., Ricci R., Larocca L. M., Maggiano N., Capelli A., Scambia G., Benedetti Panici P., Mancuso S., Piantelli M. Growth-inhibitory effect of quercetin and presence of type II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer 1992; 50: 486–491
   PubMed Web of Science ®Google Scholar
• Scambia G., Ranelletti F. O., Benedetti Panici P., Piantelli M., Rumi C., Battaglia F., Larocca L. M., Capelli A., Mancuso S. Type II estrogen binding sites in a lymphoblastoid cell line and growth inhibitory effect of estrogen, antiestrogen and bioflavonoids. Int. J. Cancer 1990; 46: 1112–1116
   PubMed Web of Science ®Google Scholar
• Post J. F. M., Varma R. S. Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells. Cancer Lett. 1992; 67: 207–213
   PubMed Web of Science ®Google Scholar
• Yoshida M., Yamamoto M., Nikaido T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 1992; 52: 6676–6681
   PubMed Web of Science ®Google Scholar
• Hoffman R., Graham L., Newlands E. S. Enhanced antiproliferative action of busulphan by quercetin on leukaemia cell line K562. Br. J. Cancer 1989; 59: 347–348
   PubMed Web of Science ®Google Scholar
• Teofili L., Pierelli L., Iovino M. S., Leone G., Scambia G., De Vincenzo R., Benedetti Panici P., Menichella G., MacrÌ E., Piantelli M., Ranelletti F. O., Larocca L. M. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk. Res. 1992; 16: 497–503
   PubMed Web of Science ®Google Scholar
• Larocca L. M., Piantelli M., Leone G., Sica S., Teofili L., Benedetti Panici P., Scambia G., Mancuso S., Capelli A., Ranelletti F. O. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids. Brit. J. Haematol. 1990; 75: 489–495
   PubMed Web of Science ®Google Scholar
• Larocca L. M., Teofili L., Leone G., Sica S., Pierelli L., Menichella G., Scambia G., Benedetti Panici P., Ricci R., Piantelli M., Ranelletti F. O. Antiproliferative activity of quercetin on normal bone marrow and leukemic progenitors. Brit. J. Haematol. 1991; 79: 562–566
   PubMed Web of Science ®Google Scholar
• Larocca L. M., MacrÌ E., Ricci R., Teofili L., Voso M. T., Leone G., Scambia G., Piantelli M., Ranelletti F. O. Presence of estrogen receptor and type II estrogen binding sites in acute lymphoid and myeloid leukemic cells. Differential sensitivity of normal bone marrow and leukemic cells to quercetin inhibitory action on colony formation. Recent advances in cellular and molecular biology (Vol. 4), R. J. Wegmann, M. A. Wegmann. Peeters Press, LeuvenBelgium 1992; 253–261
   Google Scholar
• Larocca L. M., Teofili L., Sica S., Piantelli M., Ranelletti F. O., Iovino M. S., Leone G. Bioflavonoids: A possible tool in the therapy of acute leukemias. Drug resistance in leukemia and lymphoma, G. J.L. Kaspers, R. Pieters, P. R. Twentyman, L. M. Weisenthal, A. J. P. Veerman, 1993; 271–277
   Google Scholar
• Larocca L. M., Teofili L., Sica S., Piantelli M., Maggiano N., Leone G., Ranelletti F. O. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-fjl in these cells. Blood 1995; 85: 3654–3661
   PubMed Web of Science ®Google Scholar
• Ranelletti F. O., Piantelli M., Carbone A., Rinelli A., Scambia G., Benedetti Panici P., Mancuso S. Estrogen binding sites and 17 beta-hydroxysteroid dehydrogenase activity in human peripheral blood mononuclear cells. J. Clin. Endocr. Metab. 1988; 67: 888–893
   PubMed Web of Science ®Google Scholar
• Clark J. H., Hardin J. W., Upchurch S., Ericksson H. Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. J. Biol. Chem. 1978; 253: 7630–7634
   PubMed Web of Science ®Google Scholar
• Ericksson H., Upchurch S., Hardin J. W., Peck E. J., Jr., Clark J. H. Heterogeneity of estrogen receptors in the cytosol and nuclear fraction of rat uterus. Biochem. Biophys. Res. Commun. 1978; 81: 1–7
   PubMed Web of Science ®Google Scholar
• Markaverich B. M., Roberts R. R., Alejandro M. A., Clark J. M. An endogenous inhibitor of (3H)-estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Cancer Res. 1983; 44: 1575–1579
   Google Scholar
• Markaverich B. M., Roberts R. R., Finney R. W., Clark J. M. Preliminary characterization of an endogenous inhibitor of (3H)-estradiol binding in rat uterine nuclei. J. Biol. Chem. 1983; 258: 663–671
   Google Scholar
• Markaverich B. M., Roberts R. R., Alejandro M. A., Johnnan G. A., Middleditch B. S., Clark J. M. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J. Steroid Biochem. 1988; 30: 71–78
   PubMedGoogle Scholar
• Markaverich B. M., Gregory R. R., Alejandro M. A., Kittrell F. S., Medina D., Clark J. M., Varma M., Varma R. S. Methyl p-hydroxyphenyllactate and nuclear type II binding sites in malignant cells: metabolic fate and mammary tumor growth. Cancer Res. 1990; 50: 1470–1478
   PubMed Web of Science ®Google Scholar
• Piantelli M., Rinelli A., MacrÌ E., Maggiano N., Larocca L. M., Scerrati M., Roselli R., Iacoangeli M., Scambia G., Capelli A., Ranelletti F. O. Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer 1993; 71: 193–198
   PubMed Web of Science ®Google Scholar
• Larocca L. M., Giustacchini M., Maggiano N., Ranelletti F. O., Piantelli M., Alcini E., Capelli A. Growth-inhibitory effect of quercetin and presence of typell estrogen binding sites in primary human transitional cell carcinoma. J. Urol. 1994; 152: 1029–1033
   PubMed Web of Science ®Google Scholar
• Piantelli M., Maggiano N., Ricci R., Larocca L. M., Capelli A., Scambia G., Isola G., Natali P. G., Ranelletti F. O. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J. Invest. Dermatol. 1995; 105: 248–253
   PubMed Web of Science ®Google Scholar
• Ewen M. E., Sluss H. K., Withohouse L. L., Livingston D. N. TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009–1020
   PubMed Web of Science ®Google Scholar
• Polyak K., Kato J.-Y., Solomon M. J., Sherr C. J., MassaguÈ J., Roberts J. M., Koff A. p27Kip1 a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 1994; 8: 9–22
   PubMed Web of Science ®Google Scholar
• Hannon G. J., Beach D. p15INK4B is a potential effector of TFG-pl-induced cell cycle arrest. Nature 1994; 371: 257–261
   PubMed Web of Science ®Google Scholar
• Elia G., Santoro M. G. Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells. Biochem. J. 1994; 300: 201–209
   PubMed Web of Science ®Google Scholar
• Wei Y. Q., Zhao X., Kariya Y., Fukata H., Teshigawara K., Uchida A. Induction of apoptosis by quercetin: involvment of heat shock protein. Cancer Res. 1994; 54: 4952–4957
   PubMed Web of Science ®Google Scholar
• Osman Y., Moriyama Y., Shibata A. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-, TNF, and quercetin; its application to autologous bone marrow transplantation for CML. Exp. Hematol. 1995; 23: 442–452
   Google Scholar
• Gugler R., Lschik M., Dengler M. J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 1975; 9: 229–235
   PubMed Web of Science ®Google Scholar